Completed PHASE4 INTERVENTIONAL 2-arm NCT03809702

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia and for the Prevention of Post Herpetic Neuralgia- a Randomized Controlled Trial

Sponsor: B.P. Koirala Institute of Health Sciences

Conditions Herpes Zoster

Interventions Placebo Pregabalin

Updated 7 times since 2019 Last updated: Oct 13, 2020 Started: Jul 15, 2018 Primary completion: Sep 20, 2019 Completion: Dec 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03809702, this PHASE4 trial focuses on Herpes Zoster and remains completed. Sponsored by B.P. Koirala Institute of Health Sciences, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Apr 2020 — Nov 2020 [monthly]

Recruiting PHASE4
Feb 2019 — Apr 2020 [monthly]

Recruiting PHASE4

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B.P. Koirala Institute of Health Sciences
University Grants Commission

Data source: B.P. Koirala Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dharān, Nepal